Search research articles
Contact Us
Filters
Showing results (251-260 of 276) with videos related to
Page
of 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial
Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Oncoimmunology
|
April 28, 2022
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development
Etienne S Melese, Elizabeth Franks, Rachel A Cederberg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan, Betsy Morrow, Anish Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Gastroenterology
|
April 14, 2015
A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase
Yoshitatsu Sei, Xilin Zhao, Joanne Forbes, et al.
Acta Neuropathologica
|
May 19, 2022
Recurrent ACVR1 mutations in posterior fossa ependymoma
Drew Pratt, Calixto-Hope G Lucas, Pavalan Panneer Selvam, et al.
Cancer Research Communications
|
November 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants
Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma
Beata Holkova, Adriana Zingone, Maciej Kmieciak, et al.
Cancer Immunology Research
|
November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest
Nicolas Acquavella, David Clever, Zhiya Yu, et al.
Neuro-Oncology
|
September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics
Zhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 276) with videos related to
Sort By:
Page
of 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 11, 2015
Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial
Ariel Lopez-Chavez, Anish Thomas, Arun Rajan, et al.
Oncoimmunology
|
April 28, 2022
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development
Etienne S Melese, Elizabeth Franks, Rachel A Cederberg, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 13, 2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
Raffit Hassan, Betsy Morrow, Anish Thomas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 2, 2011
Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1
Paul F Robbins, Richard A Morgan, Steven A Feldman, et al.
Gastroenterology
|
April 14, 2015
A Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase
Yoshitatsu Sei, Xilin Zhao, Joanne Forbes, et al.
Acta Neuropathologica
|
May 19, 2022
Recurrent ACVR1 mutations in posterior fossa ependymoma
Drew Pratt, Calixto-Hope G Lucas, Pavalan Panneer Selvam, et al.
Cancer Research Communications
|
November 15, 2023
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants
Shadin Ahmed, Mary Frances Wedekind, Jaydira Del Rivero, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma
Beata Holkova, Adriana Zingone, Maciej Kmieciak, et al.
Cancer Immunology Research
|
November 1, 2014
Type I cytokines synergize with oncogene inhibition to induce tumor growth arrest
Nicolas Acquavella, David Clever, Zhiya Yu, et al.
Neuro-Oncology
|
September 23, 2021
Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics
Zhichao Wu, Zied Abdullaev, Drew Pratt, et al.
Page
of 28